Therapy of lower respiratory tract infections with moxalactam.
Moxalactam was evaluated in the therapy of lower respiratory tract infections in 40 patients. The most common organisms isolated were Streptococcus pneumoniae (37.2%) and Haemophilus influenzae (21.5%). Gram-negative enteric organisms were isolated from six patients. No patient was evaluated as a tr...
Na minha lista:
| Publicado no: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society for Microbiology (ASM)
1981
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC181526/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6457557/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.19.5.801 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|